Chemoprevention of 1,2 Dimethyl Hydrazine-Induced Colon Tumor in Albino Rat by Meloxicam and its Correlation with Immunoassay of Serum CEA

Colorectal Cancer (CRC) is among the most common types of cancer in world. Globally a steadily increasing proportion elderly people world result approximately 16 million new cases by year 2021. Regarding treatment; Meloxicam was shown to prevent initiation chemical-induced tumors, and considered as anticancer agent virtue its anti-proliferative effect, capacity for cell cycle arrest, pro-apoptotic effects, also acted free radical scavenger, particular superoxide anion oxidation scavenge.